Unbiased proteomic approach identifies pathobiological profiles in the brains of preclinical models of repetitive mild traumatic brain injury, tauopathy, and amyloidosis
VISSA-PLS-DA-based metabolomics reveals a multitargeted mechanism of traditional Chinese medicine for traumatic brain injury